Replies to post #143328 on Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

Here's a link to one Otezla study with numbers that I mentioned:

Otezla vs. Etanercept for moderate/severe plaque psoriasis

I very much appreciate Karin's find. My mistake for posting during a short on-call break last night. Nonetheless, I find it curious that the primary outcome measure of the trial is not emphasized or even mentioned in the 'article'.

When the data is released my focus will be on reduction of IGA scores. Focus on targeted lesions makes more sense with topical treatments or localized therapy (e.g. phototherapy). Also, I find it curious that there are no quality of life indicators for this short trial. For a drug called "Prurisol", I'd think there would be an interest in both signs and symptoms.